These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2161551)

  • 1. Chronic administration of the 5-HT3 receptor antagonist BRL 43694; effects on reflex epilepsy and social behaviour of the Mongolian gerbil.
    Cutler MG; Piper DC
    Psychopharmacology (Berl); 1990; 101(2):244-9. PubMed ID: 2161551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioural effects in gerbils of the 5-HT3 receptor antagonists, BRL 43694 and ICS 205-930, under circumstances of high and low light intensity.
    Cutler MG
    Neuropharmacology; 1990 Jun; 29(6):515-20. PubMed ID: 2166921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An ethological study of the effects of buspirone and the 5-HT3 receptor antagonist, BRL 43694 (granisetron) on behaviour during social interactions in female and male mice.
    Cutler MG
    Neuropharmacology; 1991 Apr; 30(4):299-306. PubMed ID: 1649417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective and functional 5-hydroxytryptamine3 receptor antagonism by BRL 43694 (granisetron).
    Sanger GJ; Nelson DR
    Eur J Pharmacol; 1989 Jan; 159(2):113-24. PubMed ID: 2540014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of sub-chronic treatment with chlordiazepoxide, buspirone and the 5-HT3 receptor antagonist, BRL 46470, on the social behaviour of mice.
    Gao B; Cutler MG
    Neuropharmacology; 1992 Mar; 31(3):207-13. PubMed ID: 1630589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic BRL 43694, a selective 5-HT3 receptor antagonist, fails to alter the number of spontaneously active midbrain dopamine neurons.
    Ashby CR; Jiang LH; Wang RY
    Eur J Pharmacol; 1990 Jan; 175(3):347-50. PubMed ID: 2157603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical pharmacology of granisetron (BRL 43694), a novel specific 5-HT3 antagonist.
    Upward JW; Arnold BD; Link C; Pierce DM; Allen A; Tasker TC
    Eur J Cancer; 1990; 26 Suppl 1():S12-5. PubMed ID: 2169778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Memory enhancing effects of granisetron (BRL 43694) in a passive avoidance task.
    Chugh Y; Saha N; Sankaranarayanan A; Sharma PL
    Eur J Pharmacol; 1991 Oct; 203(1):121-3. PubMed ID: 1665786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of chlordiazepoxide, buspirone and the 5-HT3 receptor antagonist, BRL 46470, on the behaviour of oestrous and dioestrous female mice when encountering male partners.
    Gao B; Cutler MG
    Neuropharmacology; 1993 Oct; 32(10):969-75. PubMed ID: 7905193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BRL 43694, a new 5HT3 receptor antagonist, prevents cisplatin-induced emesis in dogs.
    Bhandari P; Gupta YK; Seth SD
    Methods Find Exp Clin Pharmacol; 1989 May; 11(5):361-3. PubMed ID: 2547129
    [No Abstract]   [Full Text] [Related]  

  • 11. Epilepsy and behaviour of the Mongolian gerbil: an ethological study.
    Cutler MG; Mackintosh JH
    Physiol Behav; 1989 Oct; 46(4):561-6. PubMed ID: 2602479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of acute administration of the 5-HT3 receptor antagonist, BRL 46470A, on the behaviour of mice in a two compartment light-dark box and during social interactions in their home cage and an unfamiliar neutral cage.
    Gao B; Cutler MG
    Neuropharmacology; 1992 Aug; 31(8):743-8. PubMed ID: 1356251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [BRL 43694A--a 5-hydroxytryptamine receptor blocker as an antiemetic in cytostatic therapy].
    Joss R; Rohrbach D; Buser K; Pirovino M; Karde C; Brunner K
    Schweiz Med Wochenschr; 1989 Jun; 119(23):831-4. PubMed ID: 2549616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of a 5-HT3-antagonist on the ileal brake mechanism in the rat.
    Brown NJ; French SJ; Rumsey RD; Read NW
    J Pharm Pharmacol; 1991 Jul; 43(7):517-9. PubMed ID: 1682469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of effects of 5HT3 receptor antagonists in the social interaction and elevated plus-maze tests of anxiety in the rat.
    File SE; Johnston AL
    Psychopharmacology (Berl); 1989; 99(2):248-51. PubMed ID: 2552485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pharmacokinetic study of granisetron (BRL 43694A), a selective 5-HT3 receptor antagonist: correlation with anti-emetic response.
    Carmichael J; Cantwell BM; Edwards CM; Zussman BD; Thompson S; Rapeport WG; Harris AL
    Cancer Chemother Pharmacol; 1989; 24(1):45-9. PubMed ID: 2541937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cisplatin-evoked induction of c-fos protein in the brainstem of the ferret: the effect of cervical vagotomy and the anti-emetic 5-HT3 receptor antagonist granisetron (BRL 43694).
    Reynolds DJ; Barber NA; Grahame-Smith DG; Leslie RA
    Brain Res; 1991 Nov; 565(2):231-6. PubMed ID: 1668810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of granisetron, ICS 205-930 and ondansetron on the visceral pain reflex induced by duodenal distension.
    Moss HE; Sanger GJ
    Br J Pharmacol; 1990 Jul; 100(3):497-501. PubMed ID: 2167734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Granisetron and ondansetron: effects on the ileal brake mechanism in the rat.
    Brown NJ; Horton A; Rumsey RD; Read NW
    J Pharm Pharmacol; 1993 Jun; 45(6):521-4. PubMed ID: 8103099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRL 46470A: a highly potent, selective and long acting 5-HT3 receptor antagonist with anxiolytic-like properties.
    Blackburn TP; Baxter GS; Kennett GA; King FD; Piper DC; Sanger GJ; Thomas DR; Upton N; Wood MD
    Psychopharmacology (Berl); 1993; 110(3):257-64. PubMed ID: 7831418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.